Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 2.00 | 76.50 | 0.0261 | -0.8448 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 3.00 | 76.50 | 0.0392 | -0.7938 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 58.00 | 76.50 | 0.7582 | 0.6470 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 57.00 | 76.50 | 0.7451 | 0.6270 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 156.25 | 28.48 | 82.00 | 76.50 | 1.0719 | 1.0998 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 80.00 | 76.50 | 1.0458 | 1.0638 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 156.25 | 28.48 | 87.00 | 76.50 | 1.1373 | 1.1888 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 156.25 | 28.48 | 107.00 | 76.50 | 1.3987 | 1.5308 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 156.25 | 28.48 | 716.00 | 76.50 | 9.3595 | 8.6016 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 156.25 | 28.48 | 63.00 | 76.50 | 0.8235 | 0.7453 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 156.25 | 28.48 | 64.00 | 76.50 | 0.8366 | 0.7647 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 156.25 | 28.48 | 99.00 | 76.50 | 1.2941 | 1.3965 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 156.25 | 28.48 | 105.00 | 76.50 | 1.3725 | 1.4975 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 156.25 | 28.48 | 564.00 | 76.50 | 7.3725 | 7.1217 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 156.25 | 28.48 | 91.00 | 76.50 | 1.1895 | 1.2590 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 133.00 | 76.50 | 1.7386 | 1.9479 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 156.25 | 28.48 | 71.00 | 76.50 | 0.9281 | 0.8980 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 156.25 | 28.48 | 149.00 | 76.50 | 1.9477 | 2.1925 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 156.25 | 28.48 | 82.00 | 76.50 | 1.0719 | 1.0998 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 156.25 | 28.48 | 90.00 | 76.50 | 1.1765 | 1.2415 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 156.25 | 28.48 | 90.00 | 76.50 | 1.1765 | 1.2415 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 156.25 | 28.48 | 123.00 | 76.50 | 1.6078 | 1.7907 |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 156.25 | 28.48 | 110.00 | 76.50 | 1.4379 | 1.5803 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 156.25 | 28.48 | 83.00 | 76.50 | 1.0850 | 1.1177 |